secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2024-11-01T23:59:59+00:00
Accession:  0001213900-24-093570
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo Therapeutics receives Nasdaq delisting notice for MVLS non-compliance; appeals hearing requested
--------------------------------------------------------------------------------

- Nasdaq notified CERo on Oct 30, 2024 that it failed to regain compliance with $50M MVLS requirement by Oct 29 cure period.
- Delisting scheduled for Nov 8, 2024 unless stayed by appeal; CERo requested hearing on Oct 31, 2024.
- Hearing request automatically stays suspension of common stock trading pending panel decision.
- Company intends to present a compliance plan covering both MVLS and prior bid-price deficiency disclosed Oct 25, 2024.
- No assurance of favorable panel decision or ability to regain/maintain Nasdaq compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390024093570/0001213900-24-093570-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390024093570/ea0219564-8k_cerothera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-093570

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer